Scientists generated alveolar organoids derived from human pluripotent stem cells for use as an pulmonary fibrosis model and for drug efficacy evaluation.
[Cell Death Discovery]
6445218
{6445218:GFL7UP6Y}
apa
50
1
160104
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-4d6e8cba88b179c605874fc43363f4c5%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22GFL7UP6Y%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kim%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-15%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKim%2C%20J.-H.%2C%20An%2C%20G.%20H.%2C%20Kim%2C%20J.-Y.%2C%20Rasaei%2C%20R.%2C%20Kim%2C%20W.%20J.%2C%20Jin%2C%20X.%2C%20Woo%2C%20D.-H.%2C%20Han%2C%20C.%2C%20Yang%2C%20S.-R.%2C%20Kim%2C%20J.-H.%2C%20%26amp%3B%20Hong%2C%20S.-H.%20%282021%29.%20Human%20pluripotent%20stem-cell-derived%20alveolar%20organoids%20for%20modeling%20pulmonary%20fibrosis%20and%20drug%20testing.%20%3Ci%3ECell%20Death%20Discovery%3C%5C%2Fi%3E%2C%20%3Ci%3E7%3C%5C%2Fi%3E%281%29%2C%201%26%23x2013%3B12.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41420-021-00439-7%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41420-021-00439-7%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DGFL7UP6Y%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Human%20pluripotent%20stem-cell-derived%20alveolar%20organoids%20for%20modeling%20pulmonary%20fibrosis%20and%20drug%20testing%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jung-Hyun%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geun%20Ho%22%2C%22lastName%22%3A%22An%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ji-Young%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roya%22%2C%22lastName%22%3A%22Rasaei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Woo%20Jin%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiong%22%2C%22lastName%22%3A%22Jin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dong-Hun%22%2C%22lastName%22%3A%22Woo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Choongseong%22%2C%22lastName%22%3A%22Han%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Se-Ran%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jong-Hoon%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seok-Ho%22%2C%22lastName%22%3A%22Hong%22%7D%5D%2C%22abstractNote%22%3A%22Detailed%20understanding%20of%20the%20pathogenesis%20and%20development%20of%20effective%20therapies%20for%20pulmonary%20fibrosis%20%28PF%29%20have%20been%20hampered%20by%20lack%20of%20in%20vitro%20human%20models%20that%20recapitulate%20disease%20pathophysiology.%20In%20this%20study%2C%20we%20generated%20alveolar%20organoids%20%28AOs%29%20derived%20from%20human%20pluripotent%20stem%20cells%20%28hPSCs%29%20for%20use%20as%20an%20PF%20model%20and%20for%20drug%20efficacy%20evaluation.%20Stepwise%20direct%20differentiation%20of%20hPSCs%20into%20alveolar%20epithelial%20cells%20by%20mimicking%20developmental%20cues%20in%20a%20temporally%20controlled%20manner%20was%20used%20to%20generate%20multicellular%20AOs.%20Derived%20AOs%20contained%20the%20expected%20spectrum%20of%20differentiated%20cells%2C%20including%20alveolar%20progenitors%2C%20type%201%20and%202%20alveolar%20epithelial%20cells%20and%20mesenchymal%20cells.%20Treatment%20with%20transforming%20growth%20factor%20%28TGF-%5Cu03b21%29%20induced%20fibrotic%20changes%20in%20AOs%2C%20offering%20a%20PF%20model%20for%20therapeutic%20evaluation%20of%20a%20structurally%20truncated%20form%20%28NP-011%29%20of%20milk%20fat%20globule-EGF%20factor%208%20%28MFG-E8%29%20protein.%20The%20significant%20fibrogenic%20responses%20and%20collagen%20accumulation%20that%20were%20induced%20by%20treatment%20with%20TGF-%5Cu03b21%20in%20these%20AOs%20were%20effectively%20ameliorated%20by%20treatment%20with%20NP-011%20via%20suppression%20of%20extracellular%20signal-regulated%20kinase%20%28ERK%29%20signaling.%20Furthermore%2C%20administration%20of%20NP-011%20reversed%20bleomycin-induced%20lung%20fibrosis%20in%20mice%20also%20via%20ERK%20signaling%20suppression%20and%20collagen%20reduction.%20This%20anti-fibrotic%20effect%20mirrored%20that%20following%20Pirfenidone%20and%20Nintedanib%20administration.%20Furthermore%2C%20NP-011%20interacted%20with%20macrophages%2C%20which%20accelerated%20the%20collagen%20uptake%20for%20eliminating%20accumulated%20collagen%20in%20fibrotic%20lung%20tissues.%20This%20study%20provides%20a%20robust%20in%20vitro%20human%20organoid%20system%20for%20modeling%20PF%20and%20assessing%20anti-fibrotic%20mechanisms%20of%20potential%20drugs%20and%20suggests%20that%20modified%20MGF-E8%20protein%20has%20therapeutic%20potential%20for%20treating%20PF.%22%2C%22date%22%3A%222021-03-15%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41420-021-00439-7%22%2C%22ISSN%22%3A%222058-7716%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41420-021-00439-7%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-03-15T22%3A20%3A11Z%22%7D%7D%5D%7D
Kim, J.-H., An, G. H., Kim, J.-Y., Rasaei, R., Kim, W. J., Jin, X., Woo, D.-H., Han, C., Yang, S.-R., Kim, J.-H., & Hong, S.-H. (2021). Human pluripotent stem-cell-derived alveolar organoids for modeling pulmonary fibrosis and drug testing. Cell Death Discovery, 7(1), 1–12. https://doi.org/10.1038/s41420-021-00439-7 Cite
